Project Grant R01MH140708
Award Date 8/26/26
Completion Date 6/30/31
Dollars Obligated $611K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
City of Industry, CA 91746, USA
Similar Awards
- The National Institute of Mental Health awarded Public Health Foundation Enterprises, Inc. (doing business as Heluna Health) $659,242 on March 5, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop and evaluate the PrEP Blueprint, an implementation toolkit designed to help clinics scale up and expand access to multiple types of pre-exposure prophylaxis (PrEP) options. The project unfolds in two phases. In Year 1 (Phase 1, Aim 1), the recipient will conduct...
- The National Institute of Mental Health awarded the Research Foundation For Mental Hygiene, Inc., operating through its New York State Psychiatric Institute division, $182,912 on May 18, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop, implement, and evaluate a tailored pre-exposure prophylaxis (PrEP) decision aid for young adult Black and Latino men who have sex with men and their healthcare providers. The research addresses suboptimal PrEP uptake and adherence...
- The National Institute on Drug Abuse awarded Public Health Foundation Enterprises, Inc. (doing business as Heluna Health) $1,177,338 on April 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to test and expand the Street Prep intervention, a low-barrier HIV pre-exposure prophylaxis delivery model for people who use drugs and experience homelessness in San Francisco. The project conducts a Type 2 hybrid effectiveness-implementation randomized trial enrolling 150...
- The National Institute of Mental Health awarded San Diego State University Research Foundation $736,346 on July 6, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct a randomized controlled trial testing a stepped-care intervention to improve pre-exposure prophylaxis (PrEP) adherence among young men ages 18–29 at high risk for HIV infection in the United States. The PREPSTEP trial will enroll 300 participants on PrEP who face adherence barriers. In the first phase,...
- The National Institute of Mental Health awarded the University of Washington $729,551 on May 4, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop and evaluate pharmacy-based HIV pre-exposure prophylaxis (PrEP) services, training, and financial models. The project addresses barriers to PrEP access by expanding pharmacists' capacity to prescribe and dispense PrEP independently, overcoming clinic distance and stigma that limit treatment uptake and continuity. Three...
- The National Institute of Mental Health awarded The Trustees of Columbia University in the City of New York $149,190 on August 9, 2026, under the Mental Health Research Grants program (CFDA 93.242) to characterize HIV pre-exposure prophylaxis (PrEP) need and use in Eswatini through data triangulation and novel epidemiological methods. The research will develop and compare machine learning models to predict which individuals could most benefit from PrEP in Eswatini, where adult HIV prevalence...
- The National Institute of Mental Health awarded The Johns Hopkins University $1.995 million on June 10, 2026, under the Mental Health Research Grants program (CFDA 93.242) to conduct a national study assessing the reach and public health impact of pharmacist-prescribed HIV pre-exposure prophylaxis (PrEP). The research evaluates where pharmacist-prescribed PrEP is occurring within states that permit it, which populations it reaches, and what population-level impacts it is having on HIV...
- The National Institute of Mental Health awarded Empowerx, Inc. $485,654 on September 22, 2025, under the Mental Health Research Grants program (CFDA 93.242) to develop and test PEPPI, a software platform that enables community pharmacists to prescribe post-exposure prophylaxis (PEP) and pre-exposure prophylaxis (PREP) therapies for HIV prevention. Phase I of the project applies design thinking methodology—empathize, define, ideate, prototype, and test—to develop a user-informed prototype of...
- The National Institute of Mental Health awarded $812,484 to The Trustees of the University of Pennsylvania on August 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to test the effectiveness and dissemination of a digital intervention promoting home HIV testing and linkage to PrEP among men who have sex with men in Philadelphia. The project will randomize approximately 1,000 MSM participants to an experimental arm receiving tailored social-media and SMS messages...
- The National Institute of Mental Health awarded The Regents of the University of California, San Francisco $186,970 on August 12, 2026, under the Mental Health Research Grants program (CFDA 93.242) to support research on HIV prevention strategies for adolescent girls and young women in Africa. The research quantifies unmet need for pre-exposure prophylaxis (PrEP) using demographic and health survey data from 21 countries, projects the impact of newer biomedical HIV prevention products...